RxDoctor Payments Data

Joshua Carothers, MD

Adult Reconstructive Orthopaedic Surgery · Albuquerque, NMNPI 1407020597

Payments from drug & device makers

$58,732in general payments, 2019–2025

Across 83 payments — averaging $707.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$46K
  • Encore Medical, LP$13K
  • Stryker$235
  • Smith+Nephew$93
  • Davol Inc.$50
  • DJO, LLC$37
  • plus $34 from 2 others
$10,219in research payments, 2019–2025

Across 5 payments — averaging $2043.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Encore Medical, LP$9K
  • Zimmer Biomet$748

What the payments were for

  • Consulting fees$5,60565%
  • Travel & lodging$1,37316%
  • Food & beverage$1,44817%
  • Education$1942%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Zimmer Biomet61$45,519
Encore Medical, LP7$12,764
Stryker6$235
Smith+Nephew2$93
Davol Inc.2$50
DJO, LLC3$37
Vertex1$21
Johnson & Johnson1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few adult reconstructive orthopaedic surgery providers in New Mexicoto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$231,426
Medicare patients
455
Services billed
1,341

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tramadol Hcl27$75
Amoxicillin34$40

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Albuquerque

Where these figures come from

Is this you, or does something look wrong? →